Immunome (IMNM) investor relations material

Voting matters and shareholder proposals

• Election of three Class III directors to serve until the 2029 Annual Meeting or until successors are qualified.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory approval of named executive officer compensation (say-on-pay).

• Advisory vote on the preferred frequency of future say-on-pay votes, with 'Year' as the recommended frequency.

• Board recommends voting 'For' all proposals and nominees.

Board of directors and corporate governance

• Three nominees for Class III director positions: James Boylan, Sandra M. Swain, M.D., and Philip Wagenheim.

• Directors to serve until 2029 or until successors are elected and qualified.

Executive compensation and say-on-pay

• Advisory vote to approve compensation of named executive officers.

• Advisory vote to determine frequency of future say-on-pay votes, with annual voting recommended.